Mieloma Multiplo - Tumore del polmone

from Salute e Società · host Marco Caracciolo

1. Mieloma Multiplo, Talquetamab, anticorpo bispecifico umanizzato, sviluppato da Johnson & Johnson, è ora rimborsato in Italia.2. Tumore del polmone, aumento della sopravvivenza con amivantamab più lazertinib nei pazienti con mutazione dell’EGFR.

Episode metadata supplied by the publisher feed · Published Apr 17, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Mieloma Multiplo - Tumore del polmone

0:00 6:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

LLAMADAS DESDE EL MÁS ALLÁ Y PUERTAS DEL INCONSCIENTE: ARTETERAPIA Y SUEÑOS CON MIGUEL CINTAS

Apr 12, 2026 ·99m

EL CAMINO DEL CORAZÓN: JESÚS Y EL DESPERTAR DE CONCIENCIA CON MANUEL FERNÁNDEZ MUÑOZ.

Apr 5, 2026 ·140m

LA LUZ OCULTA: EL MISTERIO ESPIRITUAL DE LA FE BAHÁ'Í CON MIGUEL CINTAS Y EL SECRETO DE LA IGLESIA DEL TEMPLE EN LONDRES

Feb 22, 2026 ·127m

Qué esconde realmente el documental The Age of Disclosure y la instrucción Ovni del Ejército IG 40-5 con Iker Jiménez

Dec 14, 2025 ·73m

¿VINIERON DE LAS ESTRELLAS? EL ASTRONAUTA DEL CASAR DE CÁCERES CON RICARDO HURTADO

Dec 7, 2025 ·72m

ASOMBROSO CASO OVNI DE CINCO JÓVENES EN LA CASCA DEL PUMA CON IVÁN VEGA

Nov 23, 2025 ·128m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Salute e Società?

This episode is 6 minutes long.

When was this Salute e Società episode published?

This episode was published on April 17, 2025.

Can I download this Salute e Società episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!